For the first time, our results demonstrate that up-regulation of RAD54L might play a key role, at least in part, in MM pathogenesis by activating myeloma cell growth, inhibiting apoptosis and impairing cell cycle progression. The gene discussed is RAD54L; the disease is Miyoshi myopathy.